[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20075920L - Assosiasjon mellom ferroquin og et artemisininderivat for behandling av malaria - Google Patents

Assosiasjon mellom ferroquin og et artemisininderivat for behandling av malaria

Info

Publication number
NO20075920L
NO20075920L NO20075920A NO20075920A NO20075920L NO 20075920 L NO20075920 L NO 20075920L NO 20075920 A NO20075920 A NO 20075920A NO 20075920 A NO20075920 A NO 20075920A NO 20075920 L NO20075920 L NO 20075920L
Authority
NO
Norway
Prior art keywords
ferroquine
malaria
treatment
artemisinin derivative
association
Prior art date
Application number
NO20075920A
Other languages
English (en)
Inventor
Laurent Fraisse
Daniel Ter-Minassian
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20075920L publication Critical patent/NO20075920L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Oppfinnelsen vedrører en kombinasjon omfattende ferroquin, som fri base, salt, hydrat eller solvat form, og et artemisininderivat. Oppfirmelsen vedrører også en farmasøytisk sammensetning omfattende ferroquin i form av dets farmasøytisk akseptable salter, ferroquinhydrat eller solvat og minst ett artemisininderivat. Oppfinnelsen vedrører videre anvendelsen av en slik kombinasjon for fi-emstilling av et preparat for behandling eller forhindring av malaria. Til slutt vedrører oppfirmelsen et kit for behandling eller forhindring av malaria.
NO20075920A 2005-04-20 2007-11-16 Assosiasjon mellom ferroquin og et artemisininderivat for behandling av malaria NO20075920L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0503932A FR2884715B1 (fr) 2005-04-20 2005-04-20 Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludisme
PCT/FR2006/000842 WO2006111647A1 (fr) 2005-04-20 2006-04-18 Association entre la ferroquine et un derive d’artemisinine pour le traitement du paludisme

Publications (1)

Publication Number Publication Date
NO20075920L true NO20075920L (no) 2007-11-16

Family

ID=35385843

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075920A NO20075920L (no) 2005-04-20 2007-11-16 Assosiasjon mellom ferroquin og et artemisininderivat for behandling av malaria

Country Status (30)

Country Link
US (1) US20120258945A1 (no)
EP (1) EP1874293A1 (no)
JP (1) JP5148478B2 (no)
KR (1) KR20080009088A (no)
CN (2) CN102836163A (no)
AP (1) AP2782A (no)
AR (1) AR054253A1 (no)
AU (1) AU2006238506B2 (no)
BR (1) BRPI0610851A2 (no)
CA (1) CA2605385A1 (no)
CR (1) CR9425A (no)
DO (1) DOP2006000092A (no)
EA (1) EA012630B1 (no)
FR (1) FR2884715B1 (no)
GT (1) GT200600157A (no)
HN (1) HN2006015130A (no)
IL (1) IL186048A0 (no)
MA (1) MA29451B1 (no)
MX (1) MX2007012645A (no)
MY (1) MY145581A (no)
NO (1) NO20075920L (no)
NZ (1) NZ562117A (no)
PA (1) PA8669801A1 (no)
PE (2) PE20061314A1 (no)
SG (1) SG161270A1 (no)
TN (1) TNSN07359A1 (no)
TW (1) TWI387456B (no)
UA (1) UA96414C2 (no)
WO (1) WO2006111647A1 (no)
ZA (1) ZA200708800B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926993B1 (fr) * 2008-02-06 2011-03-11 Sanofi Aventis Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artemisinine ou l'un de ses derives pour le traitement du paludisme
FR2952823B1 (fr) * 2009-10-30 2012-04-20 Sanofi Aventis Utilisation de la ferroquine dans le traitement ou la prevention du paludisme
FR2951945B1 (fr) 2009-11-05 2013-08-09 Sanofi Aventis Composition pharmaceutique
FR2961209B1 (fr) * 2010-06-11 2013-03-01 Sanofi Aventis Procede de synthese de la ferroquine par amination reductrice convergente.
FR2989588A1 (fr) * 2012-04-19 2013-10-25 Centre Nat Rech Scient Composes pour la prevention ou le traitement des infections par des virus de la famille des flaviviridae
ES2799398T3 (es) 2013-11-08 2020-12-17 Exthera Medical Corp Métodos para diagnosticar enfermedades infecciosas usando medios de adsorción
CN105250295B (zh) * 2014-07-07 2018-12-25 广州中医药大学科技产业园有限公司 一种联合用药物及其作为免疫调节剂的应用
WO2017015344A1 (en) * 2015-07-20 2017-01-26 University Of Vermont And State Agricultural College Use of cymanquine compounds as antimalarial agents
CN107802755A (zh) * 2017-11-08 2018-03-16 江西龙卿堂科技有限公司 一种具有防蚊防疟作用的青蒿软膏
KR102073961B1 (ko) * 2018-11-16 2020-02-05 (주)프론트바이오 메트포르민 및 페로센계 화합물을 유효성분으로 함유하는 암 예방 또는 치료용 약학적 조성물
IL299714A (en) * 2020-07-09 2023-03-01 Ceva Sante Animale Veterinary compositions for the prevention and/or treatment of leishmaniasis
US20240207251A1 (en) * 2021-04-26 2024-06-27 Min Bo SHIM Pharmaceutical composition containing artesunate or salt thereof and pyronaridine or salt thereof, for antipyresis, anti-inflammatory efficacy, anti-viral efficacy and treatment or prevention of covid-19, and method using same
CN113952360B (zh) * 2021-09-14 2023-03-10 上海交通大学 一种亚铁离子在治疗疟疾的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166154B (no) * 1987-05-08 1990-03-24 Hoechst India
ZA200602031B (en) * 2003-09-04 2007-05-30 Cipla Ltd Antimalarial compositions and process thereof

Also Published As

Publication number Publication date
NZ562117A (en) 2010-01-29
AU2006238506A1 (en) 2006-10-26
WO2006111647A1 (fr) 2006-10-26
FR2884715A1 (fr) 2006-10-27
JP5148478B2 (ja) 2013-02-20
AP2782A (en) 2013-10-31
HN2006015130A (es) 2010-08-19
SG161270A1 (en) 2010-05-27
EA012630B1 (ru) 2009-10-30
MX2007012645A (es) 2007-12-13
KR20080009088A (ko) 2008-01-24
UA96414C2 (ru) 2011-11-10
EA200702282A1 (ru) 2008-02-28
TW200716092A (en) 2007-05-01
US20120258945A1 (en) 2012-10-11
ZA200708800B (en) 2009-01-28
CR9425A (es) 2008-02-20
IL186048A0 (en) 2008-02-09
MY145581A (en) 2012-02-29
TWI387456B (zh) 2013-03-01
CN102836163A (zh) 2012-12-26
PE20061314A1 (es) 2006-12-27
JP2008536900A (ja) 2008-09-11
PA8669801A1 (es) 2006-11-09
TNSN07359A1 (en) 2008-12-31
AP2007004211A0 (en) 2007-10-31
FR2884715B1 (fr) 2007-06-15
CN101163470A (zh) 2008-04-16
CA2605385A1 (fr) 2006-10-26
AR054253A1 (es) 2007-06-13
DOP2006000092A (es) 2006-11-15
AU2006238506B2 (en) 2012-03-01
BRPI0610851A2 (pt) 2010-08-03
MA29451B1 (fr) 2008-05-02
EP1874293A1 (fr) 2008-01-09
PE20110119A1 (es) 2011-03-08
GT200600157A (es) 2006-11-07

Similar Documents

Publication Publication Date Title
NO20075920L (no) Assosiasjon mellom ferroquin og et artemisininderivat for behandling av malaria
NO20091395L (no) Nye tiofenderivater
IL238479A0 (en) c2 th5 receptor modulator preparations and methods of use
NO20082793L (no) Nye tiofenderivater
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
NO20090835L (no) Nye HIV-reverstranskriptaseinhibitorer
NO20082088L (no) Azetidiner som MEK-inhibitorer for behandling av proliferative sykdommer
DK1749818T3 (da) Phenylpiperidinderivater som serotoningenoptagelseshæmmere
NO20085257L (no) Purinonderivater som HM74a-agonister
NO20072978L (no) Nye betuinderivater, preparat derav og anvendelse derav
NO20082124L (no) Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
UA92000C2 (en) 1-benzylindole-2-carboxamide derivatives
EA200970585A1 (ru) Бензамидные производные как агонисты ер-рецепторов
MX2010003923A (es) Formulacion farmaceutica de valsartan.
MX2010003495A (es) Derivados de quinazolinadiona, su preparacion y sus aplicaciones terapeuticas.
NO20071299L (no) Vedvarende frigivelse farmasoytisk sammensetning av tolterodine
UY29859A1 (es) Derivados de 1-amino-isiquinolina,su preparación y su aplicación terapéutica
NO20054876D0 (no) Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser
DK1797088T3 (da) Hidtil ukendte chromen-2-on-derivater og anvendelse heraf som monoamin-neurotransmitter-genoptagelseshæmmere
DK1768748T4 (da) Sammensætninger omfattende strontium og vitamin D og anvendelser deraf
UY29169A1 (es) Derivados de 2-amido-4 feniltiazol, su preparacion y su aplicacion en terapeutica
NO20054441L (no) G-laktamderivater som prostaglandinagonister
NO20090421L (no) Arylpiperazinderivater og deres anvendelse
DK1816121T3 (da) 9-chlor-15-deoxyprostaglandinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som medikamenter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application